GxP Compliance for SaaS Applications: A Practical Guide for Pharmaceutical, Biotech and Medical Device Organisations

Pharmaceutical, biotechnology and medical device companies face a recurring challenge: determining whether a Software as a Service (SaaS) platform is suitable for use in GxP-regulated environments where product quality, data integrity and patient safety are non-negotiable. Cloud-based applications offer clear operational advantages—scalability, reduced infrastructure burden and continuous updates—yet they introduce questions around shared responsibility, validation, supplier qualification and lifecycle control. This whitepaper examines the regulatory landscape, the division of compliance responsibilities, the technical capabilities expected of a GxP-ready SaaS solution, and the practical steps organisations should take to select, implement and maintain such systems in a state of control.